News
FDA delays decision on Moderna’s RSV vaccine
Moderna’s first attempt to expand its commercial activities beyond COVID-19 vaccines, its respiratory syncytial virus (RSV) shot, has suffered a delay in the US.
Saturday 23 November 2024
